SCHEMBL1287113

SCHEMBL1287113

COC(=O)c1ccnc(CN2Cc3ccccc3C2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ KDM4C Q9H3R0 3/20 0.45
▸ KDM5C P41229 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ KDM6B O15054 1/20 0.45
▸ KDM2A Q9Y2K7 1/20 0.45
▸ KDM3A Q9Y4C1 1/20 0.45
▸ PRMT5 O14744 3/20 0.44
▸ WDR77 Q9BQA1 3/20 0.44
▸ JMJD6 Q6NYC1 1/20 0.43
▸ NAMPT P43490 1/20 0.43
▸ KDM5B Q9UGL1 2/20 0.43
▸ ALOX15 P16050 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ KDM5A P29375 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9736097 0.83 KDM4C (0.54) NPC1HPGDRAB9ASMN1; SMN2KDM4C
SCHEMBL1287025 0.80 KDM5C (0.51) HPGDSMN1; SMN2KDM4CKDM5CKDM4E
SCHEMBL31752670 0.77 MAPK1 (0.54) NPC1HPGDRAB9ASMN1; SMN2KDM4C
SCHEMBL580585 0.77 KDM5B (0.56) NPC1HPGDRAB9ASMN1; SMN2KDM4C
SCHEMBL1287029 0.76 KDM4C (0.44) NPC1HPGDRAB9ASMN1; SMN2KDM4C
SCHEMBL17144910 0.75 JMJD6 (0.42) NPC1HPGDRAB9ASMN1; SMN2KDM4C
SCHEMBL17835560 0.74 KDM4E (0.54) SMN1; SMN2KDM4ENAMPTLMNAMEN1
SCHEMBL10263738 0.74 KDM4E (0.57) NPC1HPGDRAB9ASMN1; SMN2KDM4C
SCHEMBL31320065 0.74 KDM4E (0.57) NPC1HPGDRAB9ASMN1; SMN2KDM4C
SCHEMBL30740808 0.74 KDM4C (0.57) NPC1HPGDRAB9ASMN1; SMN2KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047156-A1 ISOXAZOL-3(2H)-ONE ANALOGS AS PLASMINOGEN INHIBITORS AND THEIR USE IN THE TREATMENT OF FIBRINOLYSIS RELATED DISEASES ASTRAZENECA AB (SE) 2012-04-12 — — WO disclosed
Send feedback